These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38097453)

  • 41. Understanding Human Factors Challenges on the Front Lines of Mass COVID-19 Vaccination Clinics: Human Systems Modeling Study.
    Tennant R; Tetui M; Grindrod K; Burns CM
    JMIR Hum Factors; 2022 Nov; 9(4):e39670. PubMed ID: 36219839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic.
    Olusanya OA; Bednarczyk RA; Davis RL; Shaban-Nejad A
    Front Immunol; 2021; 12():663074. PubMed ID: 33815424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 vaccine safety inquiries to the centers for disease control and prevention immunization safety office.
    Miller ER; Moro PL; Shimabukuro TT; Carlock G; Davis SN; Freeborn EM; Roberts AL; Gee J; Taylor AW; Gallego R; Suragh T; Su JR
    Vaccine; 2023 Jun; 41(27):3960-3963. PubMed ID: 37248099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months-5 Years - United States, June 17, 2022-May 7, 2023.
    Hause AM; Marquez P; Zhang B; Moro PL; Myers TR; Bradley C; Bazel S; Panchanathan SS; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(23):621-626. PubMed ID: 37289661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COVID-19 Variant Surveillance and Social Determinants in Central Massachusetts: Development Study.
    Shi Q; Herbert C; Ward DV; Simin K; McCormick BA; Ellison Iii RT; Zai AH
    JMIR Form Res; 2022 Jun; 6(6):e37858. PubMed ID: 35658093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.
    ;
    MMWR Recomm Rep; 2009 Aug; 58(RR-10):1-8. PubMed ID: 19713882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Achieving Equity in Childhood Vaccination: A Mixed-Methods Study of Immunization Programs, Policies, and Coverage in 3 US States.
    Brumbaugh KQ; Ornelas IJ; Casas FR; Mokdad AH
    J Public Health Manag Pract; 2024 Jan-Feb 01; 30(1):E31-E40. PubMed ID: 37966959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of "Catch Up to Get Ahead" efforts on administration of routine childhood vaccinations during COVID-19 pandemic, United States Indian Health Service, 2020.
    Deerin JF; Gyekye-Kusi AA; Doss-Walker J; Bablak H; Kim D
    J Public Health Policy; 2022 Dec; 43(4):613-620. PubMed ID: 36352258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The new National Immunization Program 2017-2019 and the Essential Care Levels: what is going to change?].
    De Waure C; Sisti LG; Poscia A; Ricciardi W
    Ig Sanita Pubbl; 2017; 73(5):405-418. PubMed ID: 29433128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Technical guidelines for seasonal influenza vaccination in China (2023-2024)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Oct; 44(10):1507-1530. PubMed ID: 37875437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics - United States, September 1, 2022-September 30, 2023.
    El Kalach R; Jones-Jack N; Elam MA; Olorukooba A; Vazquez M; Stokley S; Meyer S; McGarvey S; Nguyen K; Scharf LG; Harris LQ; Duggar C; Moore LB
    MMWR Morb Mortal Wkly Rep; 2024 Apr; 73(13):286-290. PubMed ID: 38573866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measles outbreak response immunization during the COVID-19 pandemic: lessons from Borno State, Nigeria.
    Nomhwange T; Mohammed A; Jean Baptiste AE; Musa A; Yusuf A; Yusuf M; Wagai J; Shettima A; Meleh S; Banda R; Braka F; Luce R; Masresha B
    Pan Afr Med J; 2022; 41():104. PubMed ID: 35432705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).
    Shimabukuro TT; Nguyen M; Martin D; DeStefano F
    Vaccine; 2015 Aug; 33(36):4398-405. PubMed ID: 26209838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Challenges and changes: immunization program managers share perspectives in a 2012 national survey about the US immunization system since the H1N1 pandemic response.
    Seib K; Chamberlain A; Wells K; Curran E; Whitney EA; Orenstein WA; Hinman AR; Omer SB
    Hum Vaccin Immunother; 2014; 10(10):2915-21. PubMed ID: 25483633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19 vaccine inquiries regarding children ages 5-11 years received by NIP-INFO.
    Hall E; Morales S; Wolicki J; Schillie S
    Public Health Nurs; 2022 Sep; 39(5):1119-1122. PubMed ID: 35413142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current State of Mass Vaccination Preparedness and Operational Challenges in the United States, 2018-2019.
    Hosangadi D; Shearer MP; Warmbrod KL; Kan L; Cantu M; Nuzzo JB
    Health Secur; 2020 Dec; 18(6):473-482. PubMed ID: 33017195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Improved Immunization Record to Support Vaccination During the COVID-19 Pandemic at a University Hospital in Argentina.
    Descalzo JM; Verdineli J; Nuñez J; Díaz SV; Gambarte ML; Minoletti S; Blanco MH; Jauregui OI; Rizzato Lede DA; Otero CM; Luna DR
    Stud Health Technol Inform; 2022 Jun; 290():219-221. PubMed ID: 35673004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cognizance and mitigation of falsified immunization documentation: Analyzing the consequences for public health in Nigeria, with a focus on counterfeited COVID-19 vaccination cards: A case report.
    Ali VE; Asika MO; Elebesunu EE; Agbo C; Antwi MH
    Health Sci Rep; 2024 Feb; 7(2):e1885. PubMed ID: 38410502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.